pyrazines has been researched along with Arthritis, Rheumatoid in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, YQ; Guo, HT; He, XJ; Lu, C; Luo, D; Xiao, C; Xu, SH; Zhao, HY | 1 |
| Jimenez, SA; Roman-Blas, JA | 1 |
| Anagnostopoulos, A; Athanasiou, E; Bougiouklis, D; Kaloyannidis, P; Palladas, P; Papadopoulou, A; Paraskeva, A; Yannaki, E; Yiangou, M | 1 |
| Al, M; Assaraf, YG; Chan, ET; de Gruijl, TD; den Uyl, D; Dijkmans, BA; Jansen, G; Kirk, CJ; Oerlemans, R; Peters, GJ; Scheffer, GL; Scheper, RJ; van der Heijden, JW; Verbrugge, SE | 1 |
| Anagnostopoulos, A; Athanasiou, E; Batsis, I; Fassas, A; Kaloyannidis, P; Papadopoulou, A; Yannaki, E; Yiangou, M; Zogas, N | 1 |
| Igaki, N; Yokota, K | 1 |
| Boehncke, WH; Elliott, PJ; Zollner, TM | 1 |
| Brun, J | 1 |
2 review(s) available for pyrazines and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Targeting NF-kappaB: a promising molecular therapy in inflammatory arthritis.
Topics: Adrenal Cortex Hormones; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Boronic Acids; Bortezomib; Humans; Immunosuppression Therapy; Inflammation; Mice; NF-kappa B; Nuclear Localization Signals; Oligodeoxyribonucleotides; Pyrazines; Rats; Signal Transduction | 2008 |
Proteasome inhibition: a new anti-inflammatory strategy.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Arthritis, Rheumatoid; Asthma; Boronic Acids; Bortezomib; Clinical Trials as Topic; Cysteine Endopeptidases; Disease Models, Animal; Humans; Inflammation; Lysine; Models, Biological; Models, Chemical; Multienzyme Complexes; Multiple Sclerosis; Neoplasms; NF-kappa B; Peptides; Protease Inhibitors; Proteasome Endopeptidase Complex; Psoriasis; Pyrazines; Reperfusion Injury | 2003 |
1 trial(s) available for pyrazines and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Inactivating PSMB5 mutations and P-glycoprotein (multidrug resistance-associated protein/ATP-binding cassette B1) mediate resistance to proteasome inhibitors: ex vivo efficacy of (immuno)proteasome inhibitors in mononuclear blood cells from patients with
Topics: Arthritis, Rheumatoid; ATP Binding Cassette Transporter, Subfamily B, Member 1; Boronic Acids; Bortezomib; Cell Line, Tumor; Drug Resistance, Neoplasm; HEK293 Cells; Humans; Leukocytes, Mononuclear; Mutation; Oligopeptides; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Treatment Outcome | 2012 |
5 other study(ies) available for pyrazines and Arthritis, Rheumatoid
| Article | Year |
|---|---|
[Effect of Combination Therapy of Tetramethylpyrazine with Methotrexate on Inflammatory Reac- tions and Hemorheology in Collagen-induced Arthritis Rats].
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Cattle; Collagen Type II; Drug Therapy, Combination; Drugs, Chinese Herbal; Hemorheology; Interleukin-17; Interleukin-1beta; Interleukin-6; Male; Methotrexate; Pyrazines; Rats; Rats, Sprague-Dawley; Synovial Membrane | 2015 |
The proteasome inhibitor bortezomib drastically affects inflammation and bone disease in adjuvant-induced arthritis in rats.
Topics: Analysis of Variance; Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Bone Diseases; Boronic Acids; Bortezomib; Cell Proliferation; Cytokines; Flow Cytometry; Immunohistochemistry; Inflammation; Joints; Pyrazines; Rats; Rats, Inbred Lew; Reverse Transcriptase Polymerase Chain Reaction; Spleen; Synovial Membrane; Toll-Like Receptors; Treatment Outcome | 2010 |
Mesenchymal stem cells are conditionally therapeutic in preclinical models of rheumatoid arthritis.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Boronic Acids; Bortezomib; Disease Models, Animal; Flow Cytometry; Mesenchymal Stem Cell Transplantation; Mice; Mice, Inbred C57BL; Mice, Transgenic; Pyrazines; Rats; Rats, Inbred F344; Rats, Inbred Lew; Real-Time Polymerase Chain Reaction; T-Lymphocytes | 2012 |
Sitagliptin (DPP-4 inhibitor)-induced rheumatoid arthritis in type 2 diabetes mellitus: a case report.
Topics: Alleles; Arthritis, Rheumatoid; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Genetic Predisposition to Disease; HLA-DRB1 Chains; Humans; Middle Aged; Pyrazines; Rheumatoid Factor; Sitagliptin Phosphate; Triazoles | 2012 |
Proteasome inhibition as a novel therapy in treating rheumatoid arthritis.
Topics: Animals; Antirheumatic Agents; Apoptosis; Arthritis, Rheumatoid; Boronic Acids; Bortezomib; Cell Proliferation; Humans; Models, Biological; Protease Inhibitors; Proteasome Inhibitors; Pyrazines; Synovial Membrane | 2008 |